Telos Corporation (TLS) Earnings Call Transcripts

57 earnings calls from February 2020 to May 11, 2026

NasdaqGM US Information Technology Software

Telos Corporation's Latest Earnings Call - Q1 FY2026

In the first quarter of fiscal year 2026, Telos Corporation (TLS:US) reported a remarkable 56% year-over-year revenue growth, reaching $47.7 million, exceeding guidance of $44 million to $45 million. Adjusted EBITDA also surpassed expectations at $7.9 million, indicating strong operational efficiency and profitability improvements. Management maintained its full-year guidance but raised the low end of cash gross margin expectations, reflecting confidence in ongoing momentum despite the CEO's medical leave.

Reported metrics

MetricValueContext
Revenue $47.7 million (beat) vs $44 million to $45 million guidance, +56% YoY
Adjusted EBITDA $7.9 million (beat) vs $4.5 million to $5 million guidance
Adjusted EBITDA Margin 16.5% (beat) vs 1.2% in prior year period
Operating Cash Flow $8.7 million (null) null
Free Cash Flow $6.4 million (null) 13.4% free cash flow margin
Cash Gross Margin 42.3% (null) null

Guidance from management

For Q2 2026, management expects revenue growth of 22% to 28% year-over-year, with adjusted EBITDA between $5 million and $6 million. Full-year guidance remains unchanged but reflects increased confidence in cash gross margin.

What management said

Yes. Erik, so on PreCheck, listen, your PreCheck is an important program for us. It's 1 of several large programs within the company. We expect it to be an important growth driver for us for the year as it was in the quarter. No, we haven't seen any impact from higher fuel prices. As a matter of fact, enrollments are performing very well year-over-year, both in the first quarter as well as so far here in the second q...
— Unknown Executive, Q1 FY2026 earnings call
Sure. Yes. So seasonality typically we see enrollment as being seasonally lower in the second half. That's kind of the trend we've seen for the last couple of years. And our base case is we would expect that again this year.
— Unknown Executive, Q1 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns about the lack of guidance increase despite strong Q1 performance and the potential impact of the CEO's medical leave on operational continuity. There were inquiries about the likelihood of new business awards contributing to revenue in 2026 versus 2027.

Main topics on the call

Read the full Telos Corporation transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Telos Corporation

Telos Corporation (TLS) is a publicly listed company in the Software industry, within the Information Technology sector. It trades on NasdaqGM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 57 calls on record spanning February 12, 2020 to May 11, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 57 Telos Corporation earnings call transcripts on record, spanning February 12, 2020 to May 11, 2026. Based on this history, Telos Corporation reports quarterly. The most recent call on file is dated May 11, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
TLS
Exchange
NasdaqGM
Country
US
Sector
Information Technology
Industry
Software
Calls on record
57
First call
February 12, 2020
Most recent
May 11, 2026
Reporting cadence
quarterly
Quarter Date
Q1 FY2026 May 11, 2026 Read transcript
Q4 FY2025 Mar 16, 2026 Read transcript
Earnings Calls Feb 18, 2026 Read transcript
Q3 FY2025 Nov 10, 2025 Read transcript
Q2 FY2025 Aug 11, 2025 Read transcript
Analyst/Investor Day May 27, 2025 Read transcript
Q1 FY2025 May 9, 2025 Read transcript
Q4 FY2024 Mar 10, 2025 Read transcript
Earnings Calls Feb 19, 2025 Read transcript
Q3 FY2024 Nov 12, 2024 Read transcript
Shareholder/Analyst Calls Oct 14, 2024 Read transcript
Earnings Calls Aug 14, 2024 Read transcript
Q2 FY2024 Aug 9, 2024 Read transcript
Special Calls May 21, 2024 Read transcript
Q1 FY2024 May 10, 2024 Read transcript
Q4 FY2023 Mar 15, 2024 Read transcript
Earnings Calls Feb 14, 2024 Read transcript
Analyst/Investor Day Nov 13, 2023 Read transcript
Q3 FY2023 Nov 9, 2023 Read transcript
Shareholder/Analyst Calls Oct 16, 2023 Read transcript
Earnings Calls Aug 16, 2023 Read transcript
Q2 FY2023 Aug 9, 2023 Read transcript
Q1 FY2023 May 10, 2023 Read transcript
Q4 FY2022 Mar 16, 2023 Read transcript
Earnings Calls Feb 15, 2023 Read transcript
Q3 FY2022 Nov 9, 2022 Read transcript
Shareholder/Analyst Calls Oct 11, 2022 Read transcript
Shareholder/Analyst Calls Oct 10, 2022 Read transcript
Special Calls Sep 29, 2022 Read transcript
Earnings Calls Aug 10, 2022 Read transcript
Q2 FY2022 Aug 9, 2022 Read transcript
Q1 FY2022 May 10, 2022 Read transcript
Q4 FY2021 Mar 16, 2022 Read transcript
Earnings Calls Feb 16, 2022 Read transcript
Special Calls Feb 2, 2022 Read transcript
Special Calls Dec 7, 2021 Read transcript
Company Conference Presentations Nov 16, 2021 Read transcript
Analyst/Investor Day Nov 15, 2021 Read transcript
Q3 FY2021 Nov 15, 2021 Read transcript
M&A Calls Oct 25, 2021 Read transcript
Shareholder/Analyst Calls Oct 11, 2021 Read transcript
Special Calls Sep 29, 2021 Read transcript
Analyst/Investor Day Sep 15, 2021 Read transcript
Q2 FY2021 Aug 16, 2021 Read transcript
Earnings Calls Aug 11, 2021 Read transcript
Q1 FY2021 May 17, 2021 Read transcript
Company Conference Presentations May 11, 2021 Read transcript
Q4 FY2020 Mar 25, 2021 Read transcript
Earnings Calls Feb 10, 2021 Read transcript
M&A Calls Dec 15, 2020 Read transcript
Special Calls Dec 8, 2020 Read transcript
Company Conference Presentations Nov 18, 2020 Read transcript
Analyst/Investor Day Nov 11, 2020 Read transcript
Shareholder/Analyst Calls Oct 12, 2020 Read transcript
Earnings Calls Aug 12, 2020 Read transcript
Earnings Calls Feb 13, 2020 Read transcript
Earnings Calls Feb 12, 2020 Read transcript